Results 101 to 110 of about 21,695 (218)

Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 888-897, March 1, 2026.
ABSTRACT Background Management of coronary perforation in bifurcation lesions with covered stents remains challenging. Aims We aimed to describe a proper practice and toolbox for “jailed‐branch” management after covered stent deployment. Methods Using a bench model, we tested various wires with a 120° angulated microcatheter for their ability to ...
Rayyan Hemetsberger   +11 more
wiley   +1 more source

Endovascular Stenting for Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: From Diagnosis to Intervention

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 925-933, March 1, 2026.
ABSTRACT Background Pulmonary vein stenosis (PVS) is an uncommon but serious complication of atrial fibrillation (AF) ablation, often misinterpreted as primary pulmonary disease. Timely identification is essential to prevent irreversible injury and to guide appropriate referral for interventional management. Case Presentations Through the discussion of
Cristina Aurigemma   +14 more
wiley   +1 more source

A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and Rationale of the CYCLOPES Trial

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1018-1026, March 1, 2026.
ABSTRACT Introduction Moderate‐to‐severe calcification is present in ~20%–30% of patients undergoing coronary angiography. Coronary lesion modification is often necessary to facilitate optimal stent delivery and expansion, with several dedicated devices now approved for calcium modification before stent implantation. The CYCLOPES study aims to evaluate
Daniel O'Callaghan   +14 more
wiley   +1 more source

Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura

open access: yesCase Reports in Cardiology, 2020
A 53-year-old man was admitted to a peripheral hospital with the diagnosis of acute myocardial infarction without ST elevation. Due to the concomitant presence of first-diagnosed thrombocytopenia (platelet count 50.000/μL), it was decided to be treated ...
Nikolaos Iakovis   +6 more
doaj   +1 more source

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization [PDF]

open access: yes, 2002
BACKGROUND: The need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization.
Ban Hayashi, E. (Ernesto)   +11 more
core   +3 more sources

Treatment of Coronary Perforation in a Bifurcation: Two‐Stent Strategies With Fenestrated Covered Stents

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1080-1087, March 1, 2026.
ABSTRACT Coronary perforations are a dreaded complication for any interventional cardiologist. The treatment of this complication is exceptionally difficult when it occurs in a coronary bifurcation. While a conservative approach or a balloon occlusion might be sufficient in some cases, additional treatment is sometimes necessary.
Jakob U. Lindner   +3 more
wiley   +1 more source

BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial

open access: yesTrials, 2017
Background Severe limb ischaemia (SLI) is defined as the presence of rest pain and/or tissue loss secondary to lower extremity atherosclerotic peripheral arterial disease.
Benjamin D. Hunt   +12 more
doaj   +1 more source

Biological aspects of radiation and drug-eluting stents for the prevention of restenosis [PDF]

open access: yes, 2017
Based on recent advances, this article aims to review the biological basis for the use of either radiation or drug-eluting stents for the prevention of restenosis, and to elucidate the complementary role that they may play in the future.
Hendry, Jolyon H.   +4 more
core  

Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention [PDF]

open access: yes, 2016
Numerous advances and innovative therapies have been introduced in interventional cardiology over the recent years, since the first introduction of balloon angioplasty, but bioresorbable scaffold is certainly one of the most exciting and attracting one ...
Bourantas, CV   +6 more
core   +4 more sources

Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta‐Analysis

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1225-1236, March 1, 2026.
ABSTRACT Background Dual antiplatelet therapy (DAPT), which combines aspirin with a P2Y12 receptor inhibitor, is considered the standard of care for patients who have had percutaneous coronary intervention (PCI). This study aimed to compare indobufen‐based (DAPT) to aspirin‐based (DAPT) after PCI.
Omar Saeed   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy